An Open-Label, Single-Treatment, Single-Period, Single Dose, Clinical Phase 1 Study to Assess the Safety and Tolerability of Tetanus Vaccine in Healthy, Adult Subjects in India

Journal of Evidence Based Medicine and Healthcare
doi 10.18410/jebmh/2019/43
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Level Up Business Center

Related search

Open-Label Study to Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less Than 12 Weeks in Chronological Age

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2011English

Single-Dose Pharmacokinetics of Co-Crystal of Tramadol-Celecoxib: Results of a 4-Way Randomized Open-Label Phase I Clinical Trial in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2017English

A First-In-Human Randomized, Double-Blind, Placebo-Controlled, Single- And Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 to Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

A Phase 1, Single-Dose, Open-Label, 5-Treatment, Crossover, Pharmacokinetic Study of Comparative Bioavailability of Epinephrine Nasal Spray and EpiPen® in Healthy Adults With Seasonal Allergies

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: A Randomized, Placebo-Controlled First-In-Human Single-Dose Escalation Study

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

An Escalating Dose Study to Assess the Safety, Tolerability and Immunogenicity of a Herpes Simplex Virus DNA Vaccine, COR-1

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2016English

Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects With Renal Impairment, Including End-Stage Renal Disease

Clinical Drug Investigation
MedicinePharmacology
2014English

Correction To: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-In-Human, Single- And Multiple-Dose Study in Healthy Volunteers

Clinical Drug Investigation
MedicinePharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy